A detailed history of Oracle Investment Management Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Oracle Investment Management Inc holds 535,558 shares of BCRX stock, worth $4.05 Million. This represents 9.42% of its overall portfolio holdings.

Number of Shares
535,558
Previous 535,558 -0.0%
Holding current value
$4.05 Million
Previous $3.31 Million 23.0%
% of portfolio
9.42%
Previous 8.72%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$4.98 - $6.77 $99,420 - $135,156
-19,964 Reduced 3.59%
535,558 $3.21 Million
Q1 2023

May 15, 2023

SELL
$7.94 - $11.84 $235,595 - $351,316
-29,672 Reduced 5.07%
555,522 $4.63 Million
Q4 2022

Feb 14, 2023

SELL
$10.5 - $14.2 $525,000 - $710,000
-50,000 Reduced 7.87%
585,194 $6.72 Million
Q3 2022

Nov 14, 2022

BUY
$10.79 - $14.81 $336,648 - $462,072
31,200 Added 5.17%
635,194 $8 Million
Q2 2022

Aug 15, 2022

SELL
$7.89 - $17.88 $8.81 Million - $20 Million
-1,116,739 Reduced 64.9%
603,994 $6.39 Million
Q1 2022

May 16, 2022

BUY
$11.56 - $19.76 $578,000 - $988,000
50,000 Added 2.99%
1,720,733 $28 Million
Q4 2021

Feb 14, 2022

SELL
$11.18 - $15.46 $2.8 Million - $3.87 Million
-250,000 Reduced 13.02%
1,670,733 $23.1 Million
Q2 2021

Aug 16, 2021

SELL
$9.5 - $17.24 $4.25 Million - $7.71 Million
-446,937 Reduced 18.88%
1,920,733 $30.4 Million
Q1 2021

May 17, 2021

SELL
$7.37 - $13.61 $4.52 Million - $8.35 Million
-613,200 Reduced 20.57%
2,367,670 $24.1 Million
Q4 2020

Feb 16, 2021

BUY
$3.37 - $8.61 $1.53 Million - $3.92 Million
455,013 Added 18.01%
2,980,870 $22.2 Million
Q3 2020

Nov 16, 2020

BUY
$3.43 - $5.53 $1.8 Million - $2.91 Million
525,857 Added 26.29%
2,525,857 $8.68 Million
Q2 2020

Aug 14, 2020

BUY
$1.9 - $5.61 $3.8 Million - $11.2 Million
2,000,000 New
2,000,000 $9.53 Million

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Oracle Investment Management Inc Portfolio

Follow Oracle Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.